Related Experiment Video
Updated: Jun 20, 2026
03:07
Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
Published on: July 12, 2024
Management of symptomatic Meesmann dystrophy
Isabelle Jalbert1, Fiona Stapleton
1School of Optometry and Vision Science, University of New South Wales and Institute for Eye Research, Sydney, NSW 2052, Australia. i.jalbert@unsw.edu.au
Summary
Meesmann dystrophy, a genetic corneal condition, presents with cysts and can cause severe vision issues. This case highlights therapeutic contact lens management for severe Meesmann dystrophy symptoms.
Area of Science:
- Ophthalmology
- Genetics
- Corneal Dystrophies
Background:
- Meesmann dystrophy is an autosomal dominant inherited corneal epithelial dystrophy.
- It is characterized by intraepithelial cysts and potential metabolic abnormalities within the corneal epithelium.
Observation:
- Patients may be asymptomatic or experience irritation, lacrimation, and photophobia.
- This report details a case of Meesmann dystrophy with unusually severe symptoms and punctate epithelial keratopathy.
Findings:
- Genetic mutations in corneal epithelial keratins are implicated in Meesmann dystrophy.
- Therapeutic contact lenses can be an effective management strategy for severe symptoms.
Implications:
- Understanding the genetic basis aids in diagnosis and potential future therapies.
- This case expands management options for Meesmann dystrophy, particularly for severe presentations.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...